macular edema, irvine gass syndrome, ozurdex
Showing 76 - 100 of >10,000
Examination of Edema After Arthroscopic Shoulder Surgery
Not yet recruiting
- Edema
- +2 more
- Edema measurement
- (no location specified)
Aug 21, 2023
Diabetic Macular Edema Trial (EYP-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)
Not yet recruiting
- Diabetic Macular Edema
- EYP-1901
- Aflibercept 2Mg/0.05Ml Inj,Oph
- (no location specified)
Oct 19, 2023
Cystoid Macular Edema After Vitrectomy for Rhegmatogenous
Recruiting
- Cystoid Macular Edema
- vitrectomy
-
Bari, Italy
- +5 more
May 18, 2022
Macular Edema, Inherited Retinal Dystrophy, Laser Retinopathy Trial in Rome (subthreshold treatment with micropulsed laser)
Not yet recruiting
- Macular Edema
- +2 more
- subthreshold treatment with micropulsed laser
-
Rome, RM, ItalyIRCSS Fondazione G:B:Bietti
Jul 27, 2023
Diabetic Macular Edema With Intravitreal Aflibercept Injection
Active, not recruiting
- Diabetic Macular Edema
- Aflibercept Injection [Eylea]
-
South Dartmouth, MassachusettsAdvanced Eye Centers
Feb 17, 2022
Diabetic Macular Edema Trial in Sacramento (Micropulse Laser Treatment, Sham Treatment)
Recruiting
- Diabetic Macular Edema
- Micropulse Laser Treatment
- Sham Treatment
-
Sacramento, CaliforniaUniversity of California, Davis
Jan 25, 2022
Conventional Grid Laser Photocoagulation and Subthreshold
Recruiting
- Diabetic Macular Edema
- laser
-
Hong Kong, Chinachinese university of Hong kong
Jun 8, 2022
Diabetic Macular Edema Trial (Bevacizumab Injection [Avastin] (IVB-I), Triamcinolone Acetonide 10mg/mL (IVT-II), Bevacizumab
Completed
- Diabetic Macular Edema
- Bevacizumab Injection [Avastin] (IVB-I)
- +2 more
- (no location specified)
May 24, 2022
Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
Enrolling by invitation
- Diabetic Macular Edema
- Diabetic Retinopathy
- ADVM-022
-
Beverly Hills, California
- +6 more
Nov 4, 2022
Diabetic Macular Edema, Cataract Trial (Bevacizumab Injection)
Withdrawn
- Diabetic Macular Edema
- Cataract
- Bevacizumab Injection
- (no location specified)
Feb 17, 2021
Diabetic Macular Edema Trial in Vienna (intraoperative OCT, stand-alone OCT)
Recruiting
- Diabetic Macular Edema
- intraoperative OCT
- stand-alone OCT
-
Vienna, AustriaVienna Institute for Research in Ocular Surgery (VIROS), Hanusch
Sep 15, 2022
Macula Edema Trial in Shatin (modified Shenling Baizhu San, Placebo)
Recruiting
- Macula Edema
- modified Shenling Baizhu San
- Placebo
-
Shatin, Hong KongThe Chinese University of Hong Kong
Nov 10, 2022
Macula Edema Trial in Damieta (Triamcinolone Acetonide and sodium hyaluronate and chondroitin sulfate, Triamcinolone Acetonide
Completed
- Macula Edema
- Triamcinolone Acetonide and sodium hyaluronate and chondroitin sulfate
- Triamcinolone Acetonide alone
-
Damieta, New Damietta, EgyptEhab tharwat
May 21, 2022
Minocycline, Cystoid Macular Edema Trial in Guangzhou (minocycline)
Recruiting
- Minocycline
- Cystoid Macular Edema
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Jul 23, 2022
Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)
Recruiting
- Diabetic Macular Edema
-
Beijing, Beijing, ChinaBeijing tongren hospital affliated to capital medical university
Apr 5, 2022
Diabetic Macular Edema (DME) Trial in United States (AXT107 0.1 mg, AXT107 0.25 mg, AXT107 0.5 mg)
Active, not recruiting
- Diabetic Macular Edema (DME)
- AXT107 0.1 mg
- +2 more
-
Gilbert, Arizona
- +9 more
Jul 19, 2022
Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)
Completed
- Diabetic Macular Edema
-
Beijing, Beijing, ChinaBeijing tongren hospital affliated to capital medical university
Apr 5, 2022
Diabetic Maculopathy Trial in Winston-Salem (Spironolactone 50 mg)
Withdrawn
- Diabetic Maculopathy
- Spironolactone 50 mg
-
Winston-Salem, North CarolinaWake Forest Baptist Health
Jul 28, 2022
Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)
Not yet recruiting
- Diabetic Macular Edema (DME)
- Neovascular Age-Related Macular Degeneration (nAMD)
- aflibercept 8 mg PFS
- (no location specified)
Aug 3, 2023
Diabetic Macular Edema (DME) Trial in Canada, United States (UBX1325, Sham)
Active, not recruiting
- Diabetic Macular Edema (DME)
- UBX1325
- Sham
-
Phoenix, Arizona
- +22 more
Apr 21, 2022
Diabetic Macular Edema, Diabetic Retinopathy Trial in Australia (Dexamethasone intravitreal implant, Bevacizumab Injectable
Completed
- Diabetic Macular Edema
- Diabetic Retinopathy
- Dexamethasone intravitreal implant
- Bevacizumab Injectable Product
-
Broome, Western Australia, Australia
- +12 more
Nov 5, 2020
Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,
Recruiting
- Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
- intravitreal injection of Ranibizumab
- +3 more
-
QinÄ, Qena, EgyptAhmed Ali Ahmed Amer
Mar 15, 2022
Macular Edema Secondary to Retinal Vein Occlusion Trial in Worldwide (Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose,
Not yet recruiting
- Macular Edema Secondary to Retinal Vein Occlusion
- Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
- +3 more
-
Fullerton, California
- +311 more
Apr 28, 2023
Diabete Type 2, Cataract, Triamcinolone Acetonide Trial in Damascus (Triamcinolone Acetonide)
Completed
- Diabete Type 2
- +3 more
- Triamcinolone Acetonide
-
Damascus, Syrian Arab RepublicDamascus University
Oct 21, 2022